Putting an NFL field smack bang in the middle of the stadium means a vast amount of space is left over before you come close ...

Arrowhead Pharmaceuticals recently received the FDA NDA acceptance for Plozasiran. Read why I believe ARWR stock could be a ...

AMD's Q4 report showed mixed results, but the company is poised for strong future growth. See why I remain very bullish on ...

Even better, the rapid growth in the customer count and Palantir's ability to win a bigger share of its customers' wallets led to a remarkable year-over-year jump of 40% in its remaining deal value ...

Equity markets have been volatile over the past week as some of the industry leaders in artificial intelligence (AI) -- which ...

The economy could be too strong for Trump's tariffs to derail the outlook for stocks, investors and economists told BI.

Mortgage rates could go up because of a trade war between the United States and Canada, Mexico and China, according to real ...

Palantir's other metrics showed that its AI platform (AIP) is continuing to drive growth and separate it from the competition ...

Since Palantir reported results, Yahoo Finance data shows there have been several upward revisions to EPS expectations for ...

Palantir (NASDAQ:PLTR) shares are off to a hot start to the year, now up close to 35% year to date. It’s only been January ...

Hilton expects 6% to 7% net unit growth for 2025. For the fourth quarter, systemwide revenue per available room moved up by 3.5%, which was above the high end of Hilton's guidance, with growth in its ...

Follow all the latest U.S. market action for Tuesday as stocks stage a recovery amid lingering tariff angst; Alphabet ...